Send Message
Home > products > Rhematoid Arthritis > Tofacitinib Citrate (540737-29-9)

Tofacitinib Citrate (540737-29-9)

Product:
Tofacitinib
Description:
CAS: 540737-29-9; tofacitinib manufacturer; tofacitinib vitiligo; alopecia tofacitinib
Category:
Rhematoid Arthritis
In-stock:
In Stock
Payment Method:
L/C, T/T
Shipping Method:
AIR, Express
Specifications
CAS:
540737-29-9
Specification:
CP, EP, As Required
M.F.:
C22H28N6O8
M.W.:
504.50
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:

Tofacitinib Citrate 540737-29-9

,

tofacitinib vitiligo CAS: 540737-29-9

,

CAS: 540737-29-9 alopecia tofacitinib

Introduction

Tofacitinib citrate is a Janus kinase inhibitor, trade name Xeljanz, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients.

 

 

 

Product Name: Tofacitinib Citrate
CAS No.: 540737-29-9
Assay: 99%
Specification: CP, EP, In-house, as required
Molecular Formula: C22H28N6O8
Molecular Weight: 504.50
Shelf Life: 2 Years
Package: 25kg/drum

 

Tofacitinib Citrate (540737-29-9) 0

Tofacitinib Citrate (540737-29-9) 1

Tofacitinib Citrate (540737-29-9) 2

Send RFQ
Stock:
In Stock
MOQ: